- Resource
- BR1DGE
- Infographic
- Staging
The T1D Communication Toolkit
The Early-stage T1D: Communication Toolkit is a clear, simple resource for healthcare professionals to support effective, age-appropriate communication with individuals undergoing screening for T1D islet autoantibodies or receiving test results.
Learning Objectives
This toolkit aims to:
- Support clear communication between clinicians and people undergoing T1D autoantibody screening
- Provide example language for clinicians demonstrating how to tailor their language and communication style depending on an individual’s age
EDENT1FI (European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception)
This work is supported by the Innovative Health Initiative under grant agreement No. 101132379 (EDENT1FI). This Joint Undertaking receives support from the European Union’s Horizon Europe research and innovation program, from The Leona M. and Harry B. Helmsley Charitable Trust, from Breakthrough T1D, from EFPIA, from COCIR, from Vaccines Europe, from EuropaBio and from MedTech. Additional funding is provided to associated UK partners through the UK Research and Innovation (UKRI) Guarantee Fund.
EDENT1FI is funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.
INNODIA
INNODIA is an international non-profit organization providing specialized services to medicine developers focused on curative therapies for people living with type 1 diabetes (T1D). These services are delivered through its network of members and INPACT associates (the trained community of people living with T1D).
.svg){kind=small}
MAT-GLB-2600553 - 1.0 - 04/2026
BR1DGE Talk Show: Timing Matters - The Evolving Story of Type 1 Diabetes
Explore how decades of advancements in biomarkers, genetics, and staging frameworks have culminated in our ability to “see” T1D before symptoms emerge.
BR1DGE Talk Show: The Impact of Late Diagnosis
Explore how diabetic ketoacidosis (DKA) affects people with T1D and their families, and learn why early detection through autoantibody screening can prevent this crisis.
Early T1D Screening Recommendations
Expert insights on recommendations for T1D screening, including proposed age ranges and opportunities for integration into existing public health touchpoints.